1NP Stock Overview
Flerie Invest AB is a venture capital firm specializing in early-stage investments.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Flerie AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.021 |
| 52 Week High | SEK 0.038 |
| 52 Week Low | SEK 0.021 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -44.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1NP | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -36.6% | -3.7% | -0.5% |
| 1Y | n/a | -20.5% | 1.6% |
Return vs Industry: Insufficient data to determine how 1NP performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1NP performed against the German Market.
Price Volatility
| 1NP volatility | |
|---|---|
| 1NP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 1NP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 1NP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Ted Fjallman | www.flerie.com |
Flerie Invest AB is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.
Flerie AB (publ) Fundamentals Summary
| 1NP fundamental statistics | |
|---|---|
| Market cap | €318.36m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 1NP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1NP income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 1NP perform over the long term?
See historical performance and comparison